This means more dilution, no thanks. I feel by moving the trials out of the USA we will finally get fair representation from a reputable source. Once the trial completes the results will speak for itself.
People can deny these conspiracy theories with our FDA but given the fact other BP drugs received approval and Leronlimab hasn’t speaks fir itself.
Given the fact that we are about to start the new trial and I feel we are in the best position ever, I question the integrity of the 13d group and their intentions. I find it suspicious of the timing.
If the trials fail in Brazil then let’s hear what they have to say.
I’m totally fine with waiting an additional 6-8 months for the results. I feel it would be foolish to make a change at this crucial point in time.
If the 13d group submits a plan who’s to say that won’t change midstream? At least NP has kept dilution to a minimum and has show the tenacity to keep moving forward with all the obstacles that have been presented to the company. He cares and is passionate about saving lives.
Everyone will make their own decisions but no one can deny the deck has been stacked against Cytodyn. Brazil will be our breakthrough.
IMO